NEW YORK (GenomeWeb) – Transposagen announced today that it has licensed CRISPR/Cas9 intellectual property from the Broad Institute.

With the non-exclusive license agreement, Transposagen will be able to combine CRISPR/Cas9 genome editing technology with its Footprint-Free Gene Editing System. The combination allows for "precision gene editing without fear of undesired off-target effects," Transposagen CEO John Printen said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.